Cancer Res 1997
L 1 and L H adjust mutant p53 aggregation by increasing zinc ion levels in cells and promoting interactions between zinc ions and mutant p53
Yes, thats why our abstract title asks, Too much of a good thing? When Im talking to patients about going on these drugs, theyre like, I dont want to go on another medicine. I say, You know what
However, the mortality rates in the DXN and combination treatment (DXN + TIR) groups were 30% and 40%, respectively, on day 12, which was the end of the study (Figure 2)
In a study, people have lost an average of nearly 29% of their body weight over about 16 monthsthe highest result seen for any weight-loss medication to date
At Advanced Medical Care, we dont believe in one-size-fits-all sleep solutions